Skip to content

Public FDA record

Z-1462-2022: nordicBrainEX, software versions 2.21 through 2.3.10

Recall record Z-1462-2022 for NordicNeuroLab AS. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1462-2022
Company in FDA record
NordicNeuroLab AS
FDA record creation date
Jul 25, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

When exporting merged results from the BOLD, DSC, and DCE modules of nordicBrainEx, where both the underlay and overlay originated from a multiframe dataset, the resulting output may have left/right sides flipped.

Source facts

Action
The firm sent a notice regarding a Critical Bug in nordicBrainEx version 2.2.1 to 2.3.10 on 06/16/2022 by email. The notice explained the problem and advised users to use extra caution when viewing the exported results. A software revision will be released to correct the issue.
Initiated
2022-06-16
Root cause
Software design
Terminated
2024-09-04
Distribution
US Nationwide distribution.
Recall number
Z-1462-2022
Recall status
Terminated
CDRH record ID
194531
FDA record created
2022-07-25
Recall event number
90480

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗